Milestone Pharmaceuticals Inc. - Common Shares — Financial Statements (NASDAQ:MIST) | MetaTrader

Open full chart

News

This Sphere Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thurs

Milestone Pharmaceuticals: Reiterating Sell As The Losses Compound (NASDAQ:MIST)

Milestone Pharmaceuticals (MIST) Reports Q2 Loss, Lags Revenue Estimates

After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Milestone Pharmaceuticals (MIST)

Milestone Pharmaceuticals Inc. (MIST) Shareholder/Analyst Call Prepared Remarks Transcript

Milestone Pharmaceuticals: Here Comes The Revenue Ramp (NASDAQ:MIST)

Milestone Pharmaceuticals: Taking The Long View (NASDAQ:MIST)

Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call Transcript

Milestone Reports Q1 Results, Highlights Initial CARDAMYST Sales - Milestone Pharmaceuticals (NASDAQ:MIST

Milestone Pharmaceuticals (MIST) Reports Q1 Loss, Lags Revenue Estimates

Milestone Pharmaceuticals Inc. (MIST) Q4 2025 Earnings Call Transcript

Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Milestone Pharmaceuticals (NASDAQ:MIST)